4.8 Article

Alzheimer's disease pathology: pathways between central norepinephrine activity, memory, and neuropsychiatric symptoms

Related references

Note: Only part of the references are listed.
Article Biochemistry & Molecular Biology

Increased tau phosphorylation follows impeded dopamine clearance in a P301L and novel P301L/COMT-deleted (DM) tau mouse model

Jeremy Koppel et al.

JOURNAL OF NEUROCHEMISTRY (2019)

Review Clinical Neurology

NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease

Clifford R. Jack et al.

ALZHEIMERS & DEMENTIA (2018)

Review Neurosciences

Long Road to Ruin: Noradrenergic Dysfunction in Neurodegenerative Disease

David Weinshenker

TRENDS IN NEUROSCIENCES (2018)

Article Neurosciences

Neuropathologic Correlates of Psychiatric Symptoms in Alzheimer's Disease

Alexander J. Ehrenberg et al.

JOURNAL OF ALZHEIMERS DISEASE (2018)

Article Neurosciences

Locus coeruleus cellular and molecular pathology during the progression of Alzheimer's disease

Sarah C. Kelly et al.

ACTA NEUROPATHOLOGICA COMMUNICATIONS (2017)

Article Clinical Neurology

Low Normal Cerebrospinal Fluid Aβ42 Levels Predict Clinical Progression in Nondemented Subjects

Betty M. Tijms et al.

ANNALS OF NEUROLOGY (2017)

Article Biochemistry & Molecular Biology

Causes, consequences, and cures for neuroinflammation mediated via the locus coeruleus: noradrenergic signaling system

Douglas L. Feinstein et al.

JOURNAL OF NEUROCHEMISTRY (2016)

Article Neurosciences

Neuronal activity enhances tau propagation and tau pathology in vivo

Jessica W. Wu et al.

NATURE NEUROSCIENCE (2016)

Article Neurosciences

Brain Region-Specific Monoaminergic Correlates of Neuropsychiatric Symptoms in Alzheimer's Disease

Yannick Vermeiren et al.

JOURNAL OF ALZHEIMERS DISEASE (2014)

Article Geriatrics & Gerontology

Psychotic Alzheimer's disease is associated with gender-specific tau phosphorylation abnormalities

Jeremy Koppel et al.

NEUROBIOLOGY OF AGING (2014)

Article Clinical Neurology

Neural reserve, neuronal density in the locus ceruleus, and cognitive decline

Robert S. Wilson et al.

NEUROLOGY (2013)

Review Clinical Neurology

Where, when, and in what form does sporadic Alzheimer's disease begin?

Heiko Braak et al.

CURRENT OPINION IN NEUROLOGY (2012)

Article Geriatrics & Gerontology

The noradrenaline precursor L-DOPS reduces pathology in a mouse model of Alzheimer's disease

Sergey Kalinin et al.

NEUROBIOLOGY OF AGING (2012)

Article Clinical Neurology

The pathological process underlying Alzheimer's disease in individuals under thirty

Heiko Braak et al.

ACTA NEUROPATHOLOGICA (2011)

Article Neurosciences

CSF Tau, A beta(42), and MHPG Differentiate Dementia with Lewy Bodies from Alzheimer's Disease

Marjolein B. Aerts et al.

JOURNAL OF ALZHEIMERS DISEASE (2011)

Review Clinical Neurology

Cerebrospinal fluid and plasma biomarkers in Alzheimer disease

Kaj Blennow et al.

NATURE REVIEWS NEUROLOGY (2010)

Article Multidisciplinary Sciences

Locus ceruleus controls Alzheimer's disease pathology by modulating microglial functions through norepinephrine

Michael T. Heneka et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)

Article Multidisciplinary Sciences

Decreased Clearance of CNS β-Amyloid in Alzheimer's Disease

Kwasi G. Mawuenyega et al.

SCIENCE (2010)

Review Neurosciences

The locus coeruleus and noradrenergic modulation of cognition

Susan J. Sara

NATURE REVIEWS NEUROSCIENCE (2009)

Review Medical Laboratory Technology

Current state and future directions of neurochemical biomarkers for Alzheimer's disease

Dankille de Jong et al.

CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2007)

Review Biochemistry & Molecular Biology

Noradrenergic regulation of inflammatory gene expression in brain

DL Feinstein et al.

NEUROCHEMISTRY INTERNATIONAL (2002)

Article Neurosciences

Noradrenergic changes, aggressive behavior, and cognition in patients with dementia

KL Matthews et al.

BIOLOGICAL PSYCHIATRY (2002)